View in EDS HTML Full Text PDF Full Text

Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study.

Saved in:
Bibliographic Details
Title: Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study.
Authors: Savolainen M; Neurocenter, Helsinki University Hospital, and Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland., Soilu-Hänninen M; Neurocenter, Turku University Hospital and Division of Clinical Neurosciences, University of Turku, Turku, Finland., Nurmi H; StellarQ Ltd, Turku, Finland., Viitala M; Aastat Ltd, Turku, Finland., Tienari P; Neurocenter, Helsinki University Hospital, and Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland., Atula S; Neurocenter, Helsinki University Hospital, and Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland., Laakso SM; Neurocenter, Helsinki University Hospital, and Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland.
Source: European journal of neurology [Eur J Neurol] 2026 May; Vol. 33 (5), pp. e70625.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42141836
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Savolainen+M%22">Savolainen M</searchLink>; Neurocenter, Helsinki University Hospital, and Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Soilu-Hänninen+M%22">Soilu-Hänninen M</searchLink>; Neurocenter, Turku University Hospital and Division of Clinical Neurosciences, University of Turku, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Nurmi+H%22">Nurmi H</searchLink>; StellarQ Ltd, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Viitala+M%22">Viitala M</searchLink>; Aastat Ltd, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Tienari+P%22">Tienari P</searchLink>; Neurocenter, Helsinki University Hospital, and Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Atula+S%22">Atula S</searchLink>; Neurocenter, Helsinki University Hospital, and Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Laakso+SM%22">Laakso SM</searchLink>; Neurocenter, Helsinki University Hospital, and Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229506311%22">European journal of neurology</searchLink> [Eur J Neurol] 2026 May; Vol. 33 (5), pp. e70625.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9506311 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-1331 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213515101%22">13515101 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Neurol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42141836
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/ene.70625
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70625
    Titles:
      – TitleFull: Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Savolainen M
      – PersonEntity:
          Name:
            NameFull: Soilu-Hänninen M
      – PersonEntity:
          Name:
            NameFull: Nurmi H
      – PersonEntity:
          Name:
            NameFull: Viitala M
      – PersonEntity:
          Name:
            NameFull: Tienari P
      – PersonEntity:
          Name:
            NameFull: Atula S
      – PersonEntity:
          Name:
            NameFull: Laakso SM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1468-1331
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: European journal of neurology
              Type: main
ResultId 1